J Dig Cancer Res.
2020 Jun;8(1):51-55.
Prophylaxis of Venous Thromboembolism in Patients with Pancreatic Cancer
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
Abstract
- Prognosis of patients with pancreatic cancer is poor due to difficulty in early diagnosis and low resectability rate at the time of diagnosis. Apart from the progression of cancer, venous thromboembolism― a complication that can increase patient mortality ― is known to occur frequently in pancreatic cancer. This review was aimed at identifying whether venous thromboembolism is more common in pancreatic cancer than in other cancer types. In addition, we reviewed several studies to determine whether thromboprophylaxis increases the survival rates of patients with pancreatic cancer.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Guideline for the Prophylaxis of Venous Thromboembolism in Hip Surgery Patients
- Comparison of Hematologic Changes between Rivaroxaban and Aspirin for Venous Thromboembolism Prophylaxis after Total Knee Arthroplasty
- Comparative Study of Compliance for Venous Thromboembolism Prophylaxis (American College of Chest Physicians Guideline and American College of Orthopedic Surgeons Guideline) in High Risk Patients with a Venous Thromboembolism
- Acute Pulmonary Embolism due to Thrombus-in-Transit in the Right Atrium During Bipolar Endoprosthesis of the Hip
- Clinical Year in Review of Venous Thromboembolism
